category,datetime,headline,id,image,related,source,summary,url
company,1768253481,NEW YORK MARKET CLOSE: Wall Street shakes off criminal probe of Powell,138078733,,JPM,Fintel,,https://finnhub.io/api/news?id=6de8a10734a0b6b60936648a18be0b8cb86e61d813ac1d3f87d3c615029e91ff
company,1768246058,Equities Rise Intraday Amid Probe Into Fed Chair Powell,138078019,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"US benchmark equity indexes were higher intraday, while gold prices hit new records as markets react",https://finnhub.io/api/news?id=9a264eff65ac87f1bb67b0065bdb575ee5b15227a65975302c90cf655805aea7
company,1768245006,Vinson & Elkins Represents JPMorgan Chase & Co. in $450 Million Thermoplastics Divestiture,138078020,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"By Karen Roman Vinson & Elkins said it represented JPMorgan Chase & Co. (NYSE: JPM) as financial advisor to The Saudi Basic Industries Corporation in the $450 million sale of its regional engineering thermoplastics business in the Americas and Europe to MUTARES. The Saudi Basic Corp. produces polycarbonate, polybutylene terephthalate and other resin and compounds […]",https://finnhub.io/api/news?id=1f994471d1f9891d1abd15441653ec576b4fa75b7fcf68bdb3c6463bbbf14f19
company,1768244170,"US Equity Indexes Mixed, Gold Scales New Peak as Powell Labels DoJ Probe 'Pretext' to Influence Policy",138078021,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,US equity indexes traded mixed while precious metals broke records in midday trading on Monday after,https://finnhub.io/api/news?id=1f10b4edbbf771613e0c96d72e4de6012f5e61a4d9edd8796b79a51437fd6b42
company,1768243467,Sizing Up Whether The Global Select Equity ETF Is A Buy Right Now,138077965,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"The JPMorgan (NYSE:JPM) Global Select Equity ETF (NASDAQ:JGLO) launched in September 2023 to actively select the best equity ideas globally. With $7.1 billion in assets and a 0.47% expense ratio, it holds roughly 40 companies. JGLO’s 15% gain over the past year stems from heavy concentration in mega-cap technology. The fund places over a quarter ... Sizing Up Whether The Global Select Equity ETF Is A Buy Right Now",https://finnhub.io/api/news?id=fb113774345d433b3af6719de2938da09195e4c8a2cca37cd98ff507d0cec4ee
company,1768243200,Traders Are Moving Past Powell's Investigation: U.S. Stock Index Outlook And Pre-CPI Trading Levels,138079125,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2214651343/image_2214651343.jpg?io=getty-c-w1536,JPM,SeekingAlpha,"Stocks caught a bid immediately after the open as participants shrugged off the headlines, using the early drop as yet another buying opportunity.",https://finnhub.io/api/news?id=5ad658b45921686f6dfbf79f7abb28c54a99fb07c656cf4dc1b6ae8ee1c0509c
company,1768243022,"JPM Preannouncements: Why Alnylam And Sarepta Lost, But Day One Won",138078023,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,Alnylam stock slipped Monday after its fourth-quarter preannouncement ahead of the J.P. Morgan Healthcare Conference.,https://finnhub.io/api/news?id=7d06c927eaadf8f0888bcb67eceeb5786d758e8a3ef1c73fd175c9246e4664ec
company,1768242976,Xpeng Stock Jumps Ahead of Flying Car IPO in Hong Kong,138078024,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,Xpeng Flying Car Unit Eyes Hong Kong Market Debut,https://finnhub.io/api/news?id=9fc023f091581b11c8b34213b6439f1d06fd9b444024c667bfc6b5ea7e7bd059
company,1768242600,Bank earnings: What to expect in 2026 amid capital market changes,138078025,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Earnings season starts for major banks JPMorgan Chase (JPM), Bank of America (BAC), Citigroup (C), Morgan Stanley (MS), Wells Fargo (WFC), and Goldman Sachs (GS) this week, all of these major financial stocks set to report fourth quarter earnings results throughout the week. RBC Capital Markets analyst Gerard Cassidy shares her outlook on the investment banking sector for 2026, referencing US real GDP (gross domestic product) forecasts. Also hear Gerard Cassidy explain why President Trump's suggested 10% cap on credit card rates would have ""real negative repercussions"" for borrowers. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",https://finnhub.io/api/news?id=3a334fd5480f07ea78de4b9e3009c5cda33dafed726a1e1ef71ee9e1b4002087
company,1768239303,What I’m Watching Before Buying JP Morgan’s Active Bond ETF,138078026,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"The JPMorgan Active Bond ETF (NYSEARCA:JBND) charges a premium for active management, but has attracted $5.4 billion since its October 2023 launch by delivering outperformance when markets get volatile. The real test ahead is whether managers can continue generating alpha as corporate bond spreads compress to levels not seen in two decades. The Spread Squeeze ... What I’m Watching Before Buying JP Morgan’s Active Bond ETF",https://finnhub.io/api/news?id=68109274883d80829572528d1dd004729b6c2031dfa1c1b609430b4548741f63
company,1768239300,vVARDIS Founders Present Drill-Free Early Cavity Treatment and Unveil Global Cavity Awareness Campaign at the 2026 J.P. Morgan Healthcare Conference,138076403,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"SAN FRANCISCO, January 12, 2026--vVARDIS, a Swiss high-growth healthcare company, active in the development of innovative dental products, today presented its pioneering solution for the treatment of early cavities, Curodont™, at the 2026 J.P. Morgan Healthcare Conference. Founded by dentist-entrepreneur sisters Drs. Haley and Goly Abivardi, vVARDIS is recognized for its commitment to advancing the standard of non-invasive dental care through Curodont, its drill-free solution for dental professi",https://finnhub.io/api/news?id=691216f3ce54c1edc14e0758fc8dacebdff35b482e8117aef4e93b45cd5064d2
company,1768239204,Read This Before Buying JPMorgan’s Active Value ETF | JAVA,138078027,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Value investing rewards patience, but not all value strategies are equal. Some use passive index replication, while others employ active managers hunting for mispriced opportunities. JPMorgan Active Value ETF (NYSEARCA:JAVA) uses fundamental research to identify quality companies trading below intrinsic worth. The question is whether JPMorgan’s active management justifies the premium. Where JAVA Fits in ... Read This Before Buying JPMorgan’s Active Value ETF | JAVA",https://finnhub.io/api/news?id=8d3b68383ec60dc40080fb961c6d785380c6c1b5ba288ee6859cba02e5a583e0
company,1768238689,"Some Credit Card Issuers' Revenue May Halve Due to Trump's Rate Cap Proposal, RBC Says",138076404,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,Some credit card issuers may see their revenue slashed by more than half as a result of a 10% intere,https://finnhub.io/api/news?id=733404bfd74c2a26ad21a01e71a22dad90732959256877e590dc818ef4fbfa76
company,1768238520,Financial Stocks Fall After Trump Calls for Credit-Card Rate Cap,138077246,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Stocks in a range of financial companies fell after President Trump called for credit-card interest rates to be capped at 10% for a year, in his latest attempt to address voters' affordability concerns.",https://finnhub.io/api/news?id=7be368d3cd307f6a038823ab56b325d2efb563430f381d8b59d935936b743c80
company,1768236990,"Top Midday Stories: DOJ Opens Criminal Probe Into Fed Chair Powell; Trump Calls for 10% Credit-Card Rate Cap, Bank Shares Tumble",138076341,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"US stocks were mixed in midday trading Monday, after Federal Reserve Chair Jerome Powell said Sunday",https://finnhub.io/api/news?id=06925d19394a332fd956fd4992b82aa117f78577d0e74c703331568e6d62c0a9
company,1768236960,"Delta, United, Other Airline Stocks Fall on Trump’s Credit-Card Plan. Why It’s Overdone.",138076406,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Delta  United and other airline stocks were falling early Monday as investors assessed President Donald Trump’s call for a 10% cap on credit-card interest rates.  Airlines make billions of dollars in revenue each year from co-branded credit cards.  Delta said it received $2 billion from American Express in the third quarter alone, up 12% year-over-year, driven by co-branded card growth.",https://finnhub.io/api/news?id=0912fe33cbd85a2688621b8d2f7bc4bf0d1e507e8cfe010c80fc9b6cfbbbc26b
company,1768236480,Meta Needs So Much Capital It Hired Its Own Banker,138076325,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Meta Platforms  announced on Monday that Dina Powell McCormick, who comes from the worlds of international finance and politics, has become the company’s president and vice chairman.  The move signals Meta won’t slow its enormous artificial-intelligence data center buildout soon.  As a child, McCormick came to America as an Egyptian immigrant who spoke no English.",https://finnhub.io/api/news?id=8ee9629ed746581986985b6e1731cfb4cfd95a5aaad13dd03002efe82ad56cad
company,1768235880,‘Biotech Super Bowl’ Lands With a Thud. Stocks Slide on Lack of Deal News.,138076408,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Monday is the first day of  J.P. Morgan’s  annual healthcare investor conference, which draws thousands of investors, analysts, and executives to San Francisco each year.  There is ample precedent: Last year,  Johnson & Johnson  announced a $14.6 billion deal to acquire Intra-Cellular Therapeutics on the first day of the gathering.  The Wall Street Journal reported last week that Merck was in talks to buy the biotech Revolution Medicines for roughly $30 billion, but as of late morning, no such agreement had been announced.",https://finnhub.io/api/news?id=a8e42fa0176125b6d61a239d1fc7e9d3ac654534ef8fe6ce6ee1a22fdfcc0ed8
company,1768235220,Why Moderna Stock Is Dropping After Good News,138076409,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Moderna  offered investors a glimpse at its upcoming earnings report as it pre-announced revenue above the midpoint of its prior guidance range.  Presenting at the annual J.P. Morgan Healthcare Conference on Monday, Moderna said it expects 2025 revenue of roughly $1.9 billion, $100 million above the midpoint of the range communicated on the company’s third-quarter earnings call.  The company still expects revenue growth of up to 10% in 2026, and reiterated that it expects non-adjusted operating expenses to decline to $4.9 billion from a range of $5 billion to $5.2 billion in 2025.",https://finnhub.io/api/news?id=48c32fe82007daec1a2ffcfe3829d5a4b22d184d0dd335f747de2832aaaf4e2f
company,1768235040,Can Bank Stocks Sustain Recent Momentum?,138076410,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Big bank stocks have not only outperformed the broader market over the past year but have also outperformed the Magnificent 7 stocks by a wide margin. With earnings looming, can the positivity continue?",https://finnhub.io/api/news?id=32cf01f2f4df8651d1af25ecf8a946122acb06fa048eabafe94a0047bc7bb201
company,1768234620,Wall Street Gears up for Q4 Earnings Season,138076411,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,Wall Street Gears up for Q4 Earnings Season,https://finnhub.io/api/news?id=4c393d635ef8b27dcd8d099d649badfd907c8eacd2c46ae4d629aeee7dcbee1e
company,1768234500,"Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference",138075158,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Biohaven Ltd. (NYSE: BHVN) (""Biohaven""), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today highlighted its broad portfolio progress at the 44th Annual J.P. Morgan Healthcare Conference. A copy of the slide presentation is available on the Events and Presentations section of the Biohaven website.",https://finnhub.io/api/news?id=f5ede7d0e655e74e0861901777738bf1c484b6b40376ad94c2db729b9e938e88
company,1768234347,Trump's credit card cap would have 'real negative' impact on borrowers,138075159,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"The earnings season's starting bell has rung, and bank stocks are off to the races this week with JPMorgan Chase & Co. (JPM) and the Bank of New York Mellon (BK) set to release fourth quarter earnings results on Tuesday. Additionally, President Trump's suggestion of a 10% cap on credit card fees has dragged down shares of major credit lenders on Monday. RBC Capital Markets analyst Gerard Cassidy speaks with Julie Hyman about the impact a possible executive order could have on credit card companies. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",https://finnhub.io/api/news?id=79c30981809b19e125c3a3da4813a77a0ccd8bcd006c9360f1bbf47c482e59d9
company,1768233395,"JPM Preannouncements Take Their Toll As Alnylam Slides, Tempus, Day One Pop",138075160,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,Alnylam stock slipped Monday after its fourth-quarter preannouncement ahead of the J.P. Morgan Healthcare Conference.,https://finnhub.io/api/news?id=2456321ad8aeb8e87be5ce09b3b73a9921624b75046cb6673018393867e14bb6
company,1768231680,"Big Week for Data: Q4 Earnings, Inflation Rate",138076412,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,Big banks reporting Q4 results and a fresh CPI Inflation Rate are expected to be two highlights to enhance market activity this week.,https://finnhub.io/api/news?id=f809e7869216f962fd26f9281bbaf87ec086a15ab3c4f4d4f33cc8648678d734
company,1768231344,Big Bank Stocks Are Tumbling After Trump Said This,138076413,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,A number of banking and financial stocks slumped Monday morning after Trump over the weekend suggested that credit card interest rates should be capped.,https://finnhub.io/api/news?id=fc6cc5ebc87b753e881163beb680bd46c20053a8e69aa861a3dc5de8a249a9a0
company,1768230240,"JPMorgan Chase, AmEx, Capital One and More Stocks Dive. Trump’s Credit-Card Plan Sparks Panic.",138075161,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Citigroup JPMorgan Chase American Express Bank of America  and other financial stocks were falling early Monday after President Donald Trump called for a cap of 10% on credit-card interest rates as part of his push to ease affordability concerns.  Credit card issuers were tumbling.  Synchrony Financial  was the biggest faller in the  in early trading, down 7.2%.",https://finnhub.io/api/news?id=6778ed6b0e69b22263a8ec35a377d461995a61af71363cfda167c652e3b942e2
company,1768230180,Field Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference,138075162,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Field Medical Inc., a clinical-stage medical technology company advancing a versatile, next-generation pulsed field ablation (PFA) platform designed to support both ventricular tachycardia (VT) and atrial fibrillation (AF) ablation, today announced that its founder, Steven Mickelsen, MD, will present at the 44th annual J.P. Morgan Healthcare Conference on Thursday, Jan. 15, 2026, at 10 a.m. PT at The Westin St. Francis in San Francisco.",https://finnhub.io/api/news?id=7890d41c341d0cc5c2c5a77c3be5282449e6d34c47597d7e2b48fd52862b8929
company,1768230000,How Will Bank ETFs Perform in Light of Q4 Earnings?,138076414,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Q4 bank earnings kick off this week. Moderate beat odds; strong deal activity is a plus. But yield-curve risks may cap short-term gains in ETFs like XLF, KBWB.",https://finnhub.io/api/news?id=c0eaa5270409fbbd8c7def0fabec2b0231e0277a57e633f37bba392203ee7431
company,1768229407,"Trump threats drag Exxon, JPMorgan, & more; Allegiant's $1.5B deal",138075163,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Morning Brief host Julie Hyman and Yahoo Finance Markets and Data Editor Jared Blikre track several of Monday's top trending stock tickers, including bank and credit card stocks, like JPMorgan (JPM), Bank of America (BAC), Citigroup (C), Capital One (COF), American Express (AXP), Mastercard (MA), and Synchrony (SYF); Exxon Mobil (XOM); Allegiant Travel Company (ALGT); and Sun Country Airlines (SNCY). Watch the video above to learn more about the stories driving investor interest in these names. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",https://finnhub.io/api/news?id=7dbe738000517fc5cf8e11372ce3d8f1452a5057c313a576a5c669bc02185d51
company,1768227720,"These Stocks Are Today’s Movers: Capital One, Amex, Affirm, JPMorgan, Nvidia, Walmart, Moderna, Abercrombie, and More",138075164,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,Capital One tumbles and American Express declines after President Donald Trump calls for a cap of 10% on credit-card interest rates.,https://finnhub.io/api/news?id=b67f8dfae014376f3610632b0af7ce81a8ef83fb74dd5a6de9e3ba8c57f8c954
company,1768227300,Q4 2025 Earnings Preview: Can Corporate Profits Sustain S&P 500 Record Highs?,138077358,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/175442746/image_175442746.jpg?io=getty-c-w1536,JPM,SeekingAlpha,Q4 earnings season for US corporations begins this week with big banks. Investors will be looking at corporate earnings to assess whether the market's momentum can continue in the new year.,https://finnhub.io/api/news?id=e7922b819b80db92174ac4f698927dfa9a4d06c21d0087807758568c271741b4
company,1768227000,JPMorgan vs. PNC Financial: Which Bank Stock Has More Upside in 2026?,138075165,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Does PNC's faster earnings growth, lower valuation and strategic expansion give it the edge over JPMorgan in 2026? Let's decode.",https://finnhub.io/api/news?id=d7ac92e581a3df8c987e05bac2381c08cab63ee2b88cb92587df0f2cc46f80d7
company,1768226975,"DOJ subpoenas Fed, Sell America trade, earnings: 3 Things",138072300,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"The US Department of Justice (DOJ) has subpoenaed the Federal Reserve as it launches a criminal investigation into the central bank's Chair Jerome Powell. US stock futures (ES=F, NQ=F, YM=F) drop in Monday's premarket as Wall Street finds the ""Sell America"" trade to be back on, finding safe haven in precious metals like gold (GC=F) and silver (SI=F). Earnings season kicks off for major bank stocks and Delta Air Lines (DAL) this week. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",https://finnhub.io/api/news?id=ee12242b42ecd12aae761d30f2629c49ae4b737bdceac1fc83760a066effafc0
company,1768226960,Sector Update: Financial Stocks Higher Pre-Bell Monday,138072301,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Financial stocks were mostly lower pre-bell Monday, with the State Street Financial Select Sector SP",https://finnhub.io/api/news?id=978f387578a7c779e23e8af7dc3397f222ddb155f48528404addce3609d0bad3
company,1768226400,VIVUS Shares Progress on Pipeline and Key Program Milestones During the 44th Annual J.P. Morgan Healthcare Conference,138072302,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"CAMPBELL, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, today announced it will provide updates to its pipeline and key program milestones during the 44th Annual J.P. Morgan Healthcare Conference 2026. “During the J.P. Morgan Healthcare Conference, VIVUS will share key highlights from 2025, demonstrating ou",https://finnhub.io/api/news?id=b777db3fba892595a2c7143da3d51bc2a0b0e5724ec781c3a72e269a62da1e4f
company,1768226220,Is Bank of America Stock Worth Owning Ahead of Q4 Earnings?,138075166,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"BAC eyes Q4 gains with strong trading, stable NII and improved IB fees. Investors await 2026 guidance clarity.",https://finnhub.io/api/news?id=0b8dc78cda4128ac4c9e739005f0488b371220f1122a12b9ad41cd38e856dc17
company,1768226100,NYSE Content Advisory: Pre-Market Update + NYSE Takes Its Bell on the Road to JPMorgan's Healthcare Event,138072303,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.,https://finnhub.io/api/news?id=dbd9ca3a1382fa0e06d3571aa853856424e369c5291b9cc43843ffce0ad6bf4b
company,1768225860,Moderna Stock Rises. Revenue in 2025 Will Be Higher Than Midpoint of Guidance.,138075167,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Moderna  gave investors a glimpse at its upcoming earnings report on Monday as it pre-announced revenue above the midpoint of its prior guidance range.  Presenting at the J.P. Morgan healthcare conference on Monday,  Moderna  said it expects 2025 revenue of roughly $1.9 billion, $100 million above the midpoint of the range communicated on the company’s third-quarter earnings call.  For 2026, the company still expects revenue growth of up to 10%, and reiterated that it expects non-adjusted operating expenses to decline from $5 billion to $5.2 billion in 2025 to $4.9 billion in 2026.",https://finnhub.io/api/news?id=d7758a1d637272be03a1ae037a95bbfd3aa605adf157d70323076a5a7c11bebe
company,1768225127,Affirm stock jumps 3% as Trump’s proposed credit card rate cap sparks shift,138072304,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,Investing.com -- Affirm Holdings (NASDAQ:AFRM) stock rose 3% Monday morning after President Donald Trump called for a one-year cap on credit card interest rates at 10% starting January 20.,https://finnhub.io/api/news?id=41608cfe31b050cba391e29d501a4085241e93a5ab3f14a2f99cc3285ea499c8
company,1768220286,US Bank Shares Tumble as Trump Slams Credit Card Rates,138071482,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"The comments increase the political pressure on a slew of card issuers, including JPMorgan Chase & Co., Capital One Financial Corp. and Citigroup Inc. Card interest rates — hovering above 20% in recent years — have become a target of US lawmakers on both sides of the aisle, with bills popping up and meeting stiff resistance from the industry.  Mike Mayo, an analyst at Wells Fargo & Co., said in a note that “new potential card cap could wipe out earnings from cards for a year.”",https://finnhub.io/api/news?id=b98ec64f7aa39694f2d4def0c2a914fcf682bcbb42d8652bdde7711b939d74a6
company,1768224600,Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference,138072306,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Phase 3 X-TOLE2 topline data for azetukalner in FOS expected March 2026 followed by anticipated NDA submission in H2 2026Five additional Phase 3 azetukalner studies continuing to enroll patients in multiple indications in epilepsy and neuropsychiatry; Phase 3 X-NOVA2 topline data in MDD expected in H1 2027 Data from two Phase 1 studies of novel NaV1.7 (XEN1701) and KV7 (XEN1120) candidates expected in 2026 to support Phase 2 proof-of-concept studies in pain VANCOUVER, British Columbia and BOSTON",https://finnhub.io/api/news?id=47904c236bc52db8c490498ff1d9d03849fdce804560af00284e66ecb76cb780
company,1768223632,Credit card stocks sink after Trump proposes 10% cap on fees: 'Yikes',138071314,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,Credit card stocks sank early Monday after a proposal from President Trump took aim at the fees these companies charge customers.,https://finnhub.io/api/news?id=2b2346b7d4d3c6372263e44f185f8591c00d9c5da8021d3c62ab96c3e4120dbb
company,1768223308,"JPMorgan, Visa Stocks Fall After Trump Calls for Credit-Card Rate Cap",138071315,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Stocks in a range of financial companies fell after President Trump called for credit-card interest rates to be capped at 10% for a year, in his latest attempt to address voters' affordability concerns.",https://finnhub.io/api/news?id=dfaff595a6a512f56a475e0d1b62e7f95f5c4a7c8a793000929d7bb6d2072e98
company,1768223100,Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference,138071316,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"LOS ANGELES, January 12, 2026--Turn Therapeutics, Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted inflammatory and immunological therapies for dermatologic and infectious diseases, today announced corporate, financial, and pipeline updates in advance of its participation at the 2026 J.P. Morgan Healthcare Conference, taking place January 12–15, 2026, in San Francisco. Throughout the conference, Turn Therapeutics will participate in investor and partner meetings to",https://finnhub.io/api/news?id=ee937747ccc325754da8c09b63909e3289d76d18744ec11be703d9c1465f0738
company,1768222800,Nuvation Bio Reports Preliminary Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Ahead of 44th Annual J.P. Morgan Healthcare Conference,138071318,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"NEW YORK, January 12, 2026--Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced preliminary fourth quarter and full year 2025 net product revenue for IBTROZI® (taletrectinib) and provided a 2026 outlook ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.",https://finnhub.io/api/news?id=d1ee58f1bfe72c6231e893f0df9ffdfa981c42fb5f6acb9855b613ccc824deed
company,1768222800,Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference,138071317,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Anticipates Fourth Quarter and Full Year Results to Be Slightly Above Previously Provided Financial GuidanceNEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women’s health and family building solutions, today announced that the Company is participating in the 44th Annual JP Morgan Healthcare Conference, where it intends to discuss its updated expectations for the quarter and year ending December 31, 2025. “As the fourth qua",https://finnhub.io/api/news?id=fedb66851fb1788b15ed29db1ece9a6eaf47d83fb3a7f3d2414f043d59c2e6d2
company,1768222035,Stocks Fall Pre-Bell as Fed Chair Powell Faces Department of Justice Probe,138071319,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,The benchmark US stock measures were tracking in the red before the opening bell Monday amid Federal,https://finnhub.io/api/news?id=dc954fbc0276d687ba5f759a9f5a19458cb9e6ac646bc4250440abbdd840b7f0
company,1768221000,Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio,138071323,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Wave expects to initiate a Phase 2a multidose portion of WVE-007 INLIGHT clinical trial in individuals living with obesity with higher BMI and comorbidities in 1H 2026, and initiate new trials of WVE-007 as an add-on to incretin and as post-incretin maintenance in 2026 Initial WVE-007 240 mg single-dose data reported in 2025 demonstrated improved body composition with fat loss similar to GLP-1 at three months with muscle preservation and the potential for once or twice-yearly dosing; higher dose",https://finnhub.io/api/news?id=408849d06f9f691442dd885a97843e2945f286c6ea5dc9c880b72d9e4614f00b
company,1768221000,"iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference",138071322,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business update at the 44th Annual J.P. Morgan Healthcare Conference. Recent Operational Highlights and Financial Outlook Anticipate full year 2025 revenue to exceed high end of previously stated guidance range of $740",https://finnhub.io/api/news?id=53df7c7cc66abbba8ea6acf5c7db08d574d58b0811330bdd37a4f533d52e2dc5
company,1768220100,Royalty Pharma to Highlight Accomplishments and Provide Business Update at 44th Annual J.P. Morgan Healthcare Conference,138071324,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Royalty funding market reached record high of $10 billion in 2025, powered by synthetic royaltiesRoyalty Pharma maintained industry leadership with announced transactions of $4.7 billion Multiple potential value-creating milestones expected across development-stage portfolio in 2026, including pivotal data readouts for daraxonrasib, litifilimab and pelacarsen NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today provided an update on its business performance, includ",https://finnhub.io/api/news?id=781881dddf231cb4757d1c725991f075bc136d0a950d7729c33dfe1eda4226f7
company,1768220040,What 10% Credit-Card Rate Cap Would Mean for Your Wallet,138071325,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,President Trump’s call for a cap promises to save Americans billions in interest but also can lead to tightened access to credit.,https://finnhub.io/api/news?id=0a6d44e589d2db6c50aaae409cda0434bacacb08cad7197d432c72ff8698490f
company,1768219873,"Stocks making the biggest moves midday: Citigroup, Abercrombie, Vistra, Duolingo and more",138075805,https://image.cnbcfm.com/api/v1/image/108228553-1763579411007-gettyimages-2230841002-1010_32_ghi-plexi01988.jpeg?v=1768235608&w=1920&h=1080,JPM,CNBC,These are some of the stocks posting the largest moves in midday trading.,https://finnhub.io/api/news?id=e43056ed836c8984329ea32b572720333ff2c0f34fac75e0ad2b9cb968b8e684
company,1768219200,Syndax Reports Preliminary 2025 Financial Highlights and Provides Business Updates at the 44th Annual J.P. Morgan Healthcare Conference,138071329,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"– Approximately $44 million and $125 million in preliminary (unaudited) Revuforj® (revumenib) 4Q25 and full year 2025 net revenue, respectively – – Continued acceleration in demand following approval in R/R NPM1m AML, with an approximate 38% increase in Revuforj net revenue in 4Q25 vs. 3Q25 - – $56 million and $152 million in preliminary (unaudited) Niktimvo™ (axatilimab-csfr) 4Q25 and full year 2025 net revenue, respectively; Syndax will report its share of the Niktimvo net profit when it repor",https://finnhub.io/api/news?id=a975643fc7a52a7aa90f2221ddb8fc5772481a6b759e6a2764eeda08f535b2b7
company,1768219200,MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference,138071328,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference Interim assessment and enrollment completion for the EscharEx® VALUE Phase III trial in venous leg ulcers (VLUs) expected by year-end 2026; expansion to diabetic foot ulcers (DFUs) and pressure ulcers (PUs) anticipated in 2026 Expanded NexoBrid® manufacturing facility fully operational; regulatory approvals targeted for 2026 $17 million in 2025 revenue; financial guidance updated to $24–26 mi,https://finnhub.io/api/news?id=f34f87eb8643ac19298a36cee641c4f7b2cdb492dde74aae92cd0a32c4d6c64a
company,1768219200,Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference,138071327,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25 Earnings Call Improves 2025 expected GAAP operating expenses by $200 million since 3Q25 Earnings Call Increases 2025 projected year-end ...",https://finnhub.io/api/news?id=527cc655a715fa2f2b6acf64eefe3d67173bbfb4c02662638cb303fabf67c192
company,1768219200,Sotera Health to Showcase Continued Revenue Growth and Strategic Value Creation at 44th Annual J.P. Morgan Healthcare Conference,138071326,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"CLEVELAND, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, is presenting today at the 44th Annual J.P. Morgan Healthcare Conference. During the presentation, Management will be providing an update on Sotera Health’s business. “Sotera Health continued its solid growth trajectory in 2025, with reve",https://finnhub.io/api/news?id=daaab38917dd0925a2873564126b81c965764ba7bc96672e0420fc7d68f3e1c1
company,1768218960,"These Stocks Are Moving the Most Today: Capital One, American Express, JPMorgan, Nvidia, Alphabet, Walmart, and More",138071250,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,Capital One tumbles and American Express declines after President Donald Trump calls for a cap of 10% on credit-card interest rates.,https://finnhub.io/api/news?id=a18a653ccd61a8f8236e67b581939c4b7fd8d42c32eeb3771f883984348c162f
company,1768218840,Markets Rocked by Fed Fears. Trump-Powell Battle Could Be Decided by This Person.,138071331,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Why a new Fed might not please the president, bank earnings expectations are rising, low-cost airlines merge in $1.5 billion deal, and more news to start your day.",https://finnhub.io/api/news?id=c474c792d75b67e799815799968786965a9e0db785e691b288d82b7175a68b9d
company,1768218674,"Xpeng Hires JPMorgan, Morgan Stanley for Hong Kong Flying-Car Unit IPO",138071332,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,Xpeng Aeroht filed confidentially and may list in Hong Kong as soon as this year.,https://finnhub.io/api/news?id=9f1f68783b95a325a36143a3baa29e500acafbeefc35fbf99a6e9d464a12b1f3
company,1768218420,"Citi, JPMorgan, American Express Stocks Dive. Trump’s Credit Card Plan Sparks Panic.",138071333,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"While it isn’t clear how Trump may enact his plan, the stocks were getting hit badly in premarket trading Monday.",https://finnhub.io/api/news?id=db24c049b720f29730f844e143f710ed6a59bfc06a6760ecd0954116d0e748d9
company,1768218418,JPMorgan Q4 Preview: All Eyes on Dimon's 2026 Outlook,138071334,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,Investors gauge whether the banking giant can sustain record momentum as monetary policy shifts.,https://finnhub.io/api/news?id=5844423bcbee1cf36d0728cc73cdf21bb35f94287da1505759f7daf92938a152
company,1768218300,BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference,138071335,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"2026 poised to be a catalyst-rich year for BioNTech with continued late-stage pipeline progress with candidates across immunomodulators, antibody-drug conjugates and mRNA immunotherapiesExpected 2026 oncology milestones include seven late-stage data readouts and to have 15 Phase 3 clinical trials ongoing by year endAdditional late-stage trial readouts through 2030+ set to create multiple launch opportunities across tumor types, building BioNTech into a multi-product oncology company Financial st",https://finnhub.io/api/news?id=198b51ec5a653ebd03e8ed951acbc791fc1cd4d211d78acb446ed36bcddb0df2
company,1768207784,"Trump's credit card rate cap plan has unclear path, 'devastating' risks, bank insiders say",138075806,https://image.cnbcfm.com/api/v1/image/107343985-1701878559268-gettyimages-1827448633-AFP_34784WX.jpeg?v=1701878601&w=1920&h=1080,JPM,CNBC,"A 10% rate cap would make large swaths of the credit card industry unprofitable, especially tied to customers with less-than-ideal credit, banks say. ",https://finnhub.io/api/news?id=fdabb075920b617c66a875e50bcf8fe455666270b8dd5dd756381154f3b9c17e
company,1768203656,"Powell's criminal investigation, Google's AI shopping push, Boeing deliveries and more in Morning Squawk",138075768,https://image.cnbcfm.com/api/v1/image/108177029-1753445937974-gettyimages-2226032540-AFP_67RT8NC.jpeg?v=1768190718&w=1920&h=1080,JPM,CNBC,Here are five key things investors need to know to start the trading day.,https://finnhub.io/api/news?id=2a761b0b5d2cbe202995dcf556e712951490c75668bd02db88fdbd60611b3b61
company,1768201460,"Stocks making the biggest moves premarket: Capital One, Affirm, Walmart, Akamai, Sun Country & more",138075808,https://image.cnbcfm.com/api/v1/image/108227671-17634925752025-11-18t184810z_420172654_rc25zhaw3gya_rtrmadp_0_usa-fdic-capital-one-fin.jpeg?v=1768219922&w=1920&h=1080,JPM,CNBC,These are the stocks posting the largest moves before the bell.,https://finnhub.io/api/news?id=ea000c3cc606daca8601e52faf487e81c6112ba19afd09293e5508b9f7b0c2bf
company,1768201201,JPMorgan's looming question: What happens when CEO Jamie Dimon leaves?,138075802,https://image.cnbcfm.com/api/v1/image/108214916-17610711142025-10-21t151612z_1624131318_rc2eghaz3jto_rtrmadp_0_jpmorgan-new-york.jpeg?v=1761071152&w=1920&h=1080,JPM,CNBC,JPMorgan Chase CEO Jamie Dimon marks 20 years as CEO this month. Insiders say he remains as involved as ever managing the sprawling operations of the megabank.,https://finnhub.io/api/news?id=b21cf5b07e15490f3a1bee9acd0034982e45f006dabfa548811ecd78c8654017
company,1768200901,Top contenders to replace Jamie Dimon as CEO of JPMorgan Chase,138075810,https://image.cnbcfm.com/api/v1/image/108222463-1762447653799-gettyimages-2244833695-AMERICAN_BUSINESS_FORUM.jpeg?v=1762447681&w=1920&h=1080,JPM,CNBC,"This month marks Jamie Dimon's 20th anniversary as CEO of JPMorgan Chase. While a set timeline for Dimon's retirement has not been publicly announced, the question of who will replace him when he steps down looms large. CNBC's Hugh Son breaks down the CEO's possible successors.",https://finnhub.io/api/news?id=e977a4989b805b231ef3529ab6adb2da5524761b12a3b38d14663adbc3224cb7
company,1768195800,S&P 500 Earnings: Financials Report This Week; Expectations Are Quite High And Compares Are Tough,138070560,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1503371245/image_1503371245.jpg?io=getty-c-w1536,JPM,SeekingAlpha,"Of the companies that will report this week, the vast majority will be banks and financials. This blog post will focus on JPMorgan (JPM) and Citigroup (C). Read more here...",https://finnhub.io/api/news?id=a67630f277426b4376650e80d0932b7b203133f2dd5d3ec397555ae7613325e8
company,1768193544,"Capital One drops 7%, other banks hit after Trump calls for credit card rate cap",138075811,https://image.cnbcfm.com/api/v1/image/108251054-1768220028983-gettyimages-2233929081-McGregor250908NYCbusinesses03.jpeg?v=1768220098&w=1920&h=1080,JPM,CNBC,"Posting on Truth Social, Trump said he would ""no longer let the American Public be 'ripped off' by Credit Card Companies.""",https://finnhub.io/api/news?id=93d09c15e3ce8038dbbe92e42209219061b49bd550ef01eb9c35297aa184e20c
company,1768179992,How The Narrative Around Ninety One Group (LSE:N91) Is Shifting With JPMorgan’s Latest Targets,138068829,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Ninety One Group’s story has shifted again, with JPMorgan’s price target moving from £1.90 into the low £2s and most recently to £2.26 while the rating stays Neutral. The latest change is small in headline terms, but it reflects refreshed assumptions on revenue and future cash generation that keep the valuation work current without signalling a major change in conviction. Read on to see what is driving this evolving narrative and how you can keep on top of future updates as they come...",https://finnhub.io/api/news?id=5fa238d070cea41d113b751857bbaebc3a8eb0cb754faf3e9d5faacfdb4bb735
company,1768176981,"Stock market today: Dow, S&P 500, Nasdaq futures fall as markets react to DOJ investigation into Powell",138068830,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,Major gauges made slight losses as Wall Street prepares for a week of major releases against a backdrop of global volatility.,https://finnhub.io/api/news?id=a3880ccb274be6626d2950bcf6ebd687756dec69bd75e97a96d7335a4a297051
company,1768176679,How Recent Target Cuts Are Reframing The ASOS (LSE:ASC) Investment Story,138068831,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"ASOS has just seen its fair value trimmed slightly from £3.60 to £3.51, feeding into a lower price target of £2.40 that keeps the stock in the Neutral camp. Behind that shift is a reset in revenue growth assumptions, with the model input moving from a previously much higher figure to 35.97%, reflecting more cautious expectations for how quickly the top line may build from here. Investors who wish to monitor how these changing growth assumptions affect the ASOS narrative can follow future...",https://finnhub.io/api/news?id=40db714e9a0506f68e857f08c6584a31bec64750080499f3589c15ffd8473c65
company,1768176000,Argo Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference,138068832,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JPM,Yahoo,"Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage biotechnology company committed to developing next-generation siRNA therapies, today announced that Dr. Dongxu Shu, Co-Founder, Chairman of the Board, and Chief Executive Officer will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15th 2026 at 1:15 PM PST / 4:15 PM EST. in San Francisco, CA.",https://finnhub.io/api/news?id=a967ca65b74f2128187f25dda30fec8ea16dac1d8bc8b29032656db265706ac6
